Sodium-dependence of the potency of inhibitors of the neuronal noradrenaline carrier in the rat vas deferens

Vasa deferentia obtained from reserpine-pretreated rats were incubated (monoamine oxidase and catechol-O-methyltransferase inhibited) in media containing various concentrations of 3H-(-)noradrenaline and Na+ and initial rates of the neuronal uptake of 3H-noradrenaline measured both in the absence an...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Naunyn-Schmiedeberg's archives of pharmacology 1986-12, Vol.334 (4), p.397-402
Hauptverfasser: ZEITNER, C.-J, GRAEFE, K.-H
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 402
container_issue 4
container_start_page 397
container_title Naunyn-Schmiedeberg's archives of pharmacology
container_volume 334
creator ZEITNER, C.-J
GRAEFE, K.-H
description Vasa deferentia obtained from reserpine-pretreated rats were incubated (monoamine oxidase and catechol-O-methyltransferase inhibited) in media containing various concentrations of 3H-(-)noradrenaline and Na+ and initial rates of the neuronal uptake of 3H-noradrenaline measured both in the absence and presence of uptake inhibitors after 1 min of incubation. When rates of uptake were determined at various 3H-noradrenaline (1.0-12.2 mumol/l) and two fixed Na+ concentrations (25 and 140 mmol/l), the inhibition of uptake produced by (+)amphetamine, (-)metaraminol, desipramine, nomifensine and cocaine was competitive with respect to 3H-noradrenaline at both Na+ concentrations. While the Ki for (+)amphetamine, (-)metaraminol desipramine and nomifensine increased when the Na+ concentration was lowered, that for cocaine decreased. When the Na+ concentration was varied (10-140 mmol/l) and the 3H-noradrenaline concentration held constant (1.2 mumol/l), (+)amphetamine, (-)metaraminol, nomifensine and desipramine acted as mixed-type inhibitors with respect to Na+, and the inhibition of uptake produced by these drugs was the more pronounced, the higher the Na+ concentration. On the other hand, cocaine was competitive with Na+ and the inhibition produced by this drug was the more pronounced, the lower the Na+ concentration. It is concluded that the inhibitors of neuronal uptake tested here act in dependence on the external Na+ concentration. Desipramine and nomifensine resemble alternative amine substrates in being more potent at high than at low Na+ concentrations. On the other hand, cocaine is more potent at low than at high Na+ concentrations.
doi_str_mv 10.1007/BF00569377
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_77280562</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>77280562</sourcerecordid><originalsourceid>FETCH-LOGICAL-c342t-f4ac709188b879c000fd5fbed59e1ef4a3324168f3d985771a62c1363fbea3103</originalsourceid><addsrcrecordid>eNqFkU1LBDEMhosoun5cvAtzEA_CaD-m0_aoi6uC4EE9D502xcpsu7Yzgv_eqqsePSXhfRKSNwgdEnxGMBbnlwuMeauYEBtoRhpGa6II3UQzjKmsCVVyB-3m_IIxbgnn22ibSUoUozM0PETrp2VtYQXBQjBQRVeNz1Ct4ljK98_Sh2ff-zGm_CMGmFIMeqhCTNomKKkPUBmdkodUGr6opMfqTefKgoPC5H205fSQ4WAd99DT4upxflPf3V_fzi_uasMaOtau0UZgRaTspVCmbO0sdz1YroBAURmjDWmlY1ZJLgTRLTWEtawwmhHM9tDJ99xViq8T5LFb-mxgGHSAOOVOCCqLYfRfkDRcUcVVAU-_QZNizglct0p-qdN7R3D3-YPu7wcFPlpPnfol2F90bXrRj9e6zkYPLulgfP7FJKOclys-AJOvjhA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>14592959</pqid></control><display><type>article</type><title>Sodium-dependence of the potency of inhibitors of the neuronal noradrenaline carrier in the rat vas deferens</title><source>MEDLINE</source><source>SpringerLink Journals</source><creator>ZEITNER, C.-J ; GRAEFE, K.-H</creator><creatorcontrib>ZEITNER, C.-J ; GRAEFE, K.-H</creatorcontrib><description>Vasa deferentia obtained from reserpine-pretreated rats were incubated (monoamine oxidase and catechol-O-methyltransferase inhibited) in media containing various concentrations of 3H-(-)noradrenaline and Na+ and initial rates of the neuronal uptake of 3H-noradrenaline measured both in the absence and presence of uptake inhibitors after 1 min of incubation. When rates of uptake were determined at various 3H-noradrenaline (1.0-12.2 mumol/l) and two fixed Na+ concentrations (25 and 140 mmol/l), the inhibition of uptake produced by (+)amphetamine, (-)metaraminol, desipramine, nomifensine and cocaine was competitive with respect to 3H-noradrenaline at both Na+ concentrations. While the Ki for (+)amphetamine, (-)metaraminol desipramine and nomifensine increased when the Na+ concentration was lowered, that for cocaine decreased. When the Na+ concentration was varied (10-140 mmol/l) and the 3H-noradrenaline concentration held constant (1.2 mumol/l), (+)amphetamine, (-)metaraminol, nomifensine and desipramine acted as mixed-type inhibitors with respect to Na+, and the inhibition of uptake produced by these drugs was the more pronounced, the higher the Na+ concentration. On the other hand, cocaine was competitive with Na+ and the inhibition produced by this drug was the more pronounced, the lower the Na+ concentration. It is concluded that the inhibitors of neuronal uptake tested here act in dependence on the external Na+ concentration. Desipramine and nomifensine resemble alternative amine substrates in being more potent at high than at low Na+ concentrations. On the other hand, cocaine is more potent at low than at high Na+ concentrations.</description><identifier>ISSN: 0028-1298</identifier><identifier>EISSN: 1432-1912</identifier><identifier>DOI: 10.1007/BF00569377</identifier><identifier>PMID: 3821932</identifier><identifier>CODEN: NSAPCC</identifier><language>eng</language><publisher>Heidelberg: Springer</publisher><subject>Animals ; Biological and medical sciences ; Biological Transport, Active - drug effects ; Catecholaminergic system ; Cocaine - pharmacology ; Desipramine - pharmacology ; In Vitro Techniques ; Kinetics ; Male ; Medical sciences ; Muscle, Smooth - drug effects ; Muscle, Smooth - metabolism ; neurons ; Neurons - drug effects ; Neurons - metabolism ; Neuropharmacology ; Neurotransmitters. Neurotransmission. Receptors ; norepinephrine ; Norepinephrine - metabolism ; Pharmacology. Drug treatments ; Rats ; Rats, Inbred Strains ; sodium ; Sodium - physiology ; vas deferens ; Vas Deferens - drug effects ; Vas Deferens - metabolism</subject><ispartof>Naunyn-Schmiedeberg's archives of pharmacology, 1986-12, Vol.334 (4), p.397-402</ispartof><rights>1987 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c342t-f4ac709188b879c000fd5fbed59e1ef4a3324168f3d985771a62c1363fbea3103</citedby><cites>FETCH-LOGICAL-c342t-f4ac709188b879c000fd5fbed59e1ef4a3324168f3d985771a62c1363fbea3103</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=8325510$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/3821932$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>ZEITNER, C.-J</creatorcontrib><creatorcontrib>GRAEFE, K.-H</creatorcontrib><title>Sodium-dependence of the potency of inhibitors of the neuronal noradrenaline carrier in the rat vas deferens</title><title>Naunyn-Schmiedeberg's archives of pharmacology</title><addtitle>Naunyn Schmiedebergs Arch Pharmacol</addtitle><description>Vasa deferentia obtained from reserpine-pretreated rats were incubated (monoamine oxidase and catechol-O-methyltransferase inhibited) in media containing various concentrations of 3H-(-)noradrenaline and Na+ and initial rates of the neuronal uptake of 3H-noradrenaline measured both in the absence and presence of uptake inhibitors after 1 min of incubation. When rates of uptake were determined at various 3H-noradrenaline (1.0-12.2 mumol/l) and two fixed Na+ concentrations (25 and 140 mmol/l), the inhibition of uptake produced by (+)amphetamine, (-)metaraminol, desipramine, nomifensine and cocaine was competitive with respect to 3H-noradrenaline at both Na+ concentrations. While the Ki for (+)amphetamine, (-)metaraminol desipramine and nomifensine increased when the Na+ concentration was lowered, that for cocaine decreased. When the Na+ concentration was varied (10-140 mmol/l) and the 3H-noradrenaline concentration held constant (1.2 mumol/l), (+)amphetamine, (-)metaraminol, nomifensine and desipramine acted as mixed-type inhibitors with respect to Na+, and the inhibition of uptake produced by these drugs was the more pronounced, the higher the Na+ concentration. On the other hand, cocaine was competitive with Na+ and the inhibition produced by this drug was the more pronounced, the lower the Na+ concentration. It is concluded that the inhibitors of neuronal uptake tested here act in dependence on the external Na+ concentration. Desipramine and nomifensine resemble alternative amine substrates in being more potent at high than at low Na+ concentrations. On the other hand, cocaine is more potent at low than at high Na+ concentrations.</description><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>Biological Transport, Active - drug effects</subject><subject>Catecholaminergic system</subject><subject>Cocaine - pharmacology</subject><subject>Desipramine - pharmacology</subject><subject>In Vitro Techniques</subject><subject>Kinetics</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Muscle, Smooth - drug effects</subject><subject>Muscle, Smooth - metabolism</subject><subject>neurons</subject><subject>Neurons - drug effects</subject><subject>Neurons - metabolism</subject><subject>Neuropharmacology</subject><subject>Neurotransmitters. Neurotransmission. Receptors</subject><subject>norepinephrine</subject><subject>Norepinephrine - metabolism</subject><subject>Pharmacology. Drug treatments</subject><subject>Rats</subject><subject>Rats, Inbred Strains</subject><subject>sodium</subject><subject>Sodium - physiology</subject><subject>vas deferens</subject><subject>Vas Deferens - drug effects</subject><subject>Vas Deferens - metabolism</subject><issn>0028-1298</issn><issn>1432-1912</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1986</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkU1LBDEMhosoun5cvAtzEA_CaD-m0_aoi6uC4EE9D502xcpsu7Yzgv_eqqsePSXhfRKSNwgdEnxGMBbnlwuMeauYEBtoRhpGa6II3UQzjKmsCVVyB-3m_IIxbgnn22ibSUoUozM0PETrp2VtYQXBQjBQRVeNz1Ct4ljK98_Sh2ff-zGm_CMGmFIMeqhCTNomKKkPUBmdkodUGr6opMfqTefKgoPC5H205fSQ4WAd99DT4upxflPf3V_fzi_uasMaOtau0UZgRaTspVCmbO0sdz1YroBAURmjDWmlY1ZJLgTRLTWEtawwmhHM9tDJ99xViq8T5LFb-mxgGHSAOOVOCCqLYfRfkDRcUcVVAU-_QZNizglct0p-qdN7R3D3-YPu7wcFPlpPnfol2F90bXrRj9e6zkYPLulgfP7FJKOclys-AJOvjhA</recordid><startdate>19861201</startdate><enddate>19861201</enddate><creator>ZEITNER, C.-J</creator><creator>GRAEFE, K.-H</creator><general>Springer</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>8FD</scope><scope>FR3</scope><scope>M7Z</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>19861201</creationdate><title>Sodium-dependence of the potency of inhibitors of the neuronal noradrenaline carrier in the rat vas deferens</title><author>ZEITNER, C.-J ; GRAEFE, K.-H</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c342t-f4ac709188b879c000fd5fbed59e1ef4a3324168f3d985771a62c1363fbea3103</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1986</creationdate><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>Biological Transport, Active - drug effects</topic><topic>Catecholaminergic system</topic><topic>Cocaine - pharmacology</topic><topic>Desipramine - pharmacology</topic><topic>In Vitro Techniques</topic><topic>Kinetics</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Muscle, Smooth - drug effects</topic><topic>Muscle, Smooth - metabolism</topic><topic>neurons</topic><topic>Neurons - drug effects</topic><topic>Neurons - metabolism</topic><topic>Neuropharmacology</topic><topic>Neurotransmitters. Neurotransmission. Receptors</topic><topic>norepinephrine</topic><topic>Norepinephrine - metabolism</topic><topic>Pharmacology. Drug treatments</topic><topic>Rats</topic><topic>Rats, Inbred Strains</topic><topic>sodium</topic><topic>Sodium - physiology</topic><topic>vas deferens</topic><topic>Vas Deferens - drug effects</topic><topic>Vas Deferens - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>ZEITNER, C.-J</creatorcontrib><creatorcontrib>GRAEFE, K.-H</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biochemistry Abstracts 1</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Naunyn-Schmiedeberg's archives of pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>ZEITNER, C.-J</au><au>GRAEFE, K.-H</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Sodium-dependence of the potency of inhibitors of the neuronal noradrenaline carrier in the rat vas deferens</atitle><jtitle>Naunyn-Schmiedeberg's archives of pharmacology</jtitle><addtitle>Naunyn Schmiedebergs Arch Pharmacol</addtitle><date>1986-12-01</date><risdate>1986</risdate><volume>334</volume><issue>4</issue><spage>397</spage><epage>402</epage><pages>397-402</pages><issn>0028-1298</issn><eissn>1432-1912</eissn><coden>NSAPCC</coden><abstract>Vasa deferentia obtained from reserpine-pretreated rats were incubated (monoamine oxidase and catechol-O-methyltransferase inhibited) in media containing various concentrations of 3H-(-)noradrenaline and Na+ and initial rates of the neuronal uptake of 3H-noradrenaline measured both in the absence and presence of uptake inhibitors after 1 min of incubation. When rates of uptake were determined at various 3H-noradrenaline (1.0-12.2 mumol/l) and two fixed Na+ concentrations (25 and 140 mmol/l), the inhibition of uptake produced by (+)amphetamine, (-)metaraminol, desipramine, nomifensine and cocaine was competitive with respect to 3H-noradrenaline at both Na+ concentrations. While the Ki for (+)amphetamine, (-)metaraminol desipramine and nomifensine increased when the Na+ concentration was lowered, that for cocaine decreased. When the Na+ concentration was varied (10-140 mmol/l) and the 3H-noradrenaline concentration held constant (1.2 mumol/l), (+)amphetamine, (-)metaraminol, nomifensine and desipramine acted as mixed-type inhibitors with respect to Na+, and the inhibition of uptake produced by these drugs was the more pronounced, the higher the Na+ concentration. On the other hand, cocaine was competitive with Na+ and the inhibition produced by this drug was the more pronounced, the lower the Na+ concentration. It is concluded that the inhibitors of neuronal uptake tested here act in dependence on the external Na+ concentration. Desipramine and nomifensine resemble alternative amine substrates in being more potent at high than at low Na+ concentrations. On the other hand, cocaine is more potent at low than at high Na+ concentrations.</abstract><cop>Heidelberg</cop><cop>Berlin</cop><cop>New York, NY</cop><pub>Springer</pub><pmid>3821932</pmid><doi>10.1007/BF00569377</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0028-1298
ispartof Naunyn-Schmiedeberg's archives of pharmacology, 1986-12, Vol.334 (4), p.397-402
issn 0028-1298
1432-1912
language eng
recordid cdi_proquest_miscellaneous_77280562
source MEDLINE; SpringerLink Journals
subjects Animals
Biological and medical sciences
Biological Transport, Active - drug effects
Catecholaminergic system
Cocaine - pharmacology
Desipramine - pharmacology
In Vitro Techniques
Kinetics
Male
Medical sciences
Muscle, Smooth - drug effects
Muscle, Smooth - metabolism
neurons
Neurons - drug effects
Neurons - metabolism
Neuropharmacology
Neurotransmitters. Neurotransmission. Receptors
norepinephrine
Norepinephrine - metabolism
Pharmacology. Drug treatments
Rats
Rats, Inbred Strains
sodium
Sodium - physiology
vas deferens
Vas Deferens - drug effects
Vas Deferens - metabolism
title Sodium-dependence of the potency of inhibitors of the neuronal noradrenaline carrier in the rat vas deferens
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-19T05%3A42%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Sodium-dependence%20of%20the%20potency%20of%20inhibitors%20of%20the%20neuronal%20noradrenaline%20carrier%20in%20the%20rat%20vas%20deferens&rft.jtitle=Naunyn-Schmiedeberg's%20archives%20of%20pharmacology&rft.au=ZEITNER,%20C.-J&rft.date=1986-12-01&rft.volume=334&rft.issue=4&rft.spage=397&rft.epage=402&rft.pages=397-402&rft.issn=0028-1298&rft.eissn=1432-1912&rft.coden=NSAPCC&rft_id=info:doi/10.1007/BF00569377&rft_dat=%3Cproquest_cross%3E77280562%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=14592959&rft_id=info:pmid/3821932&rfr_iscdi=true